Search for lenalidomide
REVLIMID® (lenalidomide) - Official Patient Website
Talk with your healthcare provider to find out about options for effective forms of birth control that you may use to prevent pregnancy before, during, and ...
Lenalidomide (oral route) - Mayo Clinic
Search for a disease or condition . Type 3 or more letters to display suggested search options. When results are available, use up and down ...
… Revlimid (lenalidomide) is a prescription medicine approved in … Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types ...
Lenalidomide (Revlimid) - Cancer Research UK
Lenalidomide is a cancer drug. It is also known by its brand name Revlimid. It is a treatment for:
Lenalidomide: Uses, Interactions, Mechanism of Action - DrugBank
Lenalidomide is indicated for the treatment of adult patients with multiple myeloma (MM) in combination with dexamethasone.
Lenalidomide (Revlimid®) - Macmillan Cancer Support
blood in your urine (pee) or stools (poo); tiny red, brown or purple spots that may look like a rash – these spots can be harder to see if you have black or ...
Lenalidomide: MedlinePlus Drug Information
Show Search. Search ... Your doctor may order certain tests before and during your treatment to check your body's response to lenalidomide.
Search for lenalidomide - Clinical Trials register
Full Title: A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen ...
Clinical Trials Using Lenalidomide - NCI
Lenalidomide works by helping bone marrow to produce normal blood cells and killing cancer cells. Anti-inflammatory drugs, such as dexamethasone, lower the ...
Revlimid (Lenalidomide) - International Myeloma Foundation
Search. Donate Now. Main navigation. What Is Multiple Myeloma? A doctor gives a ... Revlimid (lenalidomide). REVLIMID® (lenalidomide) is an ...
Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy ...
Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma ... Lisa A Raedler, PhD, RPh. Medical Writer. Find articles by ...
We are in the process of updating FDA.gov content to reflect these changes. U.S. Food and Drug Administration. Search ... Lenalidomide (Revlimid).
Definition of lenalidomide - NCI Dictionary of Cancer Terms
Lenalidomide is a type of antiangiogenesis agent and a type of immunomodulating agent. Also called CC-5013 and Revlimid. More Information. Lenalidomide. Search ...
Lenalidomide - an overview | ScienceDirect Topics
You might find these chapters and articles relevant to this topic. Immunomodulatory Agents Changing the Landscape of Multiple Myeloma Treatment. Meletios A.
Lenalidomide in multiple myeloma: an evidence-based review of its ...
A search of the literature to-date did not identify any studies with patient-reported outcomes, such as quality of life, functional status, treatment ...
Lenalidomide Capsules - Teva Pharmaceuticals USA
Save money on your Revlimid® capsules prescription by switching to Teva's FDA-approved generic version, Lenalidomide Capsules. ... Search. Search. Clear. Close.
Knowledge on rare diseases and orphan drugs · Search for an orphan drug · Lenalidomide.
Lenalidomide - an overview | ScienceDirect Topics
You might find these chapters and articles relevant to this topic. Chronic Lymphocytic Leukemia. Farrukh T. Awan, John C. Byrd, in ...
Lenalidomide, bortezomib, and dexamethasone combination ...
search input. Search input auto suggest. filter your search. All Content, All Journals · Blood. Search ... thalidomide and lenalidomide has been associated with ...
Patient Characteristics and Survival Outcomes of Lenalidomide ...
Search Dropdown Menu. header search. search input. Search input auto ... Lenalidomide Refractory Multiple Myeloma Patients in the HONEUR Federated ...
Pomalidomide
MedicationPomalidomide, sold under the brand names Pomalyst and Imnovid, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma.
Ipsen
Pharma companyIpsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience.
Celgene
Pharmaceutical companyCelgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias.
Elotuzumab
MedicationElotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone, for adults that have received 1 to 3 prior therapies for the treatment of multiple myeloma.
Takeda Oncology
Pharmaceutical companyTakeda Oncology is a biopharmaceutical company based in Cambridge, Massachusetts. It is a fully owned subsidiary of Takeda Pharmaceutical.